Patents by Inventor Genadiy Kalyanov

Genadiy Kalyanov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIVIRAL NUCLEOSIDES
    Publication number: 20110172410
    Abstract: 4-Amino-1-((2R,3S,4S,5R)-5-azido-4-hydroxy-5-hydroxymethyl-3-methyl-tetrahydro-furan-2-yl)-1H-pyrimidin-2-one (22) and prodrugs thereof are hepatitis C(HCV) polymerase inhibitors. Also disclosed are compositions and methods for inhibiting HCV and treating HCV-mediated diseases, processes for making the compounds and synthetic intermediates employed in the process.
    Type: Application
    Filed: March 28, 2011
    Publication date: July 14, 2011
    Applicant: Medivir AB
    Inventors: Nils-Gunnar JOHANSSON, Genadiy Kalyanov, Joseph Armstrong Martin, David Bernard Smith, Anna Winqvist
  • Antiviral nucleosides
    Patent number: 7825239
    Abstract: 4-Amino-1-((2R,3S,4S,5R)-5-azido-4-hydroxy-5-hydroxymethyl-3-methyl-tetrahydro-furan-2-yl)-1H-pyrimidin-2-one (22) and prodrugs thereof are hepatitis C(HCV) polymerase inhibitors. Also disclosed are compositions and methods for inhibiting HCV and treating HCV-mediated diseases, processes for making the compounds and synthetic intermediates employed in the process.
    Type: Grant
    Filed: January 20, 2010
    Date of Patent: November 2, 2010
    Assignee: Medivir AB
    Inventors: Genadiy Kalyanov, Anna Winqvist
  • ANTIVIRAL NUCLEOSIDES
    Publication number: 20100130735
    Abstract: 4-Amino-1-((2R,3S,4S,5R)-5-azido-4-hydroxy-5-hydroxymethyl-3-methyl-tetrahydro-furan-2-yl)-1H-pyrimidin-2-one (22) and prodrugs thereof are hepatitis C(HCV) polymerase inhibitors. Also disclosed are compositions and methods for inhibiting HCV and treating HCV-mediated diseases, processes for making the compounds and synthetic intermediates employed in the process.
    Type: Application
    Filed: January 20, 2010
    Publication date: May 27, 2010
    Applicant: Medivir AB
    Inventors: Genadiy Kalyanov, Anna Winqvist
  • Antiviral nucleosides
    Patent number: 7666856
    Abstract: 4-Amino-1-((2R,3S,4S,5R)-5-azido-4-hydroxy-5-hydroxymethyl-3-methyl-tetrahydro-furan-2-yl)-1H-pyrimidin-2-one (22) and prodrugs thereof are hepatitis C (HCV) polymerase inhibitors. Also disclosed are compositions and methods for inhibiting HCV and treating HCV-mediated diseases, processes for making the compounds and synthetic intermediates employed in the process.
    Type: Grant
    Filed: October 10, 2007
    Date of Patent: February 23, 2010
    Assignee: Medivir AB
    Inventors: Nils-Gunnar Johansson, Genadiy Kalyanov, Joseph Armstrong Martin, David Bernard Smith, Anna Winqvist
  • Antiviral nucleosides
    Publication number: 20080152621
    Abstract: 4-Amino-1-((2R,3S,4S,5R)-5-azido-4-hydroxy-5-hydroxymethyl-3-methyl-tetrahydro-furan-2-yl)-1H-pyrimidin-2-one (22) and prodrugs thereof are hepatitis C (HCV) polymerase inhibitors. Also disclosed are compositions and methods for inhibiting HCV and treating HCV-mediated diseases, processes for making the compounds and synthetic intermediates employed in the process.
    Type: Application
    Filed: October 10, 2007
    Publication date: June 26, 2008
    Inventors: Nils-Gunnar Johansson, Genadiy Kalyanov, Joseph Armstrong Martin, David Bernard Smith, Anna Winqvist